Kashaf Waqar, and Anika Zainab. “The Tale and Trials of Efgartigimod: A Newly FDA Approved Drug for the Treatment of Myasthenia Gravis”. Journal of the Pakistan Medical Association 72, no. 11 (October 15, 2022): 2366–2367. Accessed July 27, 2026. https://www.jpma.org.pk/index.php/public_html/article/view/6388.